Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus + Methotrexate for GVHD Prevention in HSCT
NCT02660684Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2008
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus + Wuzhi capsule in graft-versus-host disease (GVHD), sponsored by Astellas Pharma. Started Feb 2008; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02660684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660684.